Motley Fool
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset
➖
AI Sentiment
Neutral
5/10
Revolution Medicines Inc. News
Latest updates and market news for RVMD
10 news
Mar 16 - Mar 22, 2026
Page 1
Motley Fool
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
📊
AI Sentiment
Positive
7/10
Motley Fool
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash
➖
AI Sentiment
Neutral
4/10
Motley Fool
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
➖
AI Sentiment
Neutral
4/10
Motley Fool
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Revolution Medicines Insider Sold Shares Worth $455,919, According to a Recent SEC Filing
📉
AI Sentiment
Negative
3/10
MT Newswires
Revolution Medicines Insider Sold Shares Worth $1,280,412, According to a Recent SEC Filing
📉
AI Sentiment
Negative
3/10
MT Newswires
Revolution Medicines Insider Sold Shares Worth $427,965, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
4/10
Motley Fool
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
📈
AI Sentiment
Highly Positive
9/10
Share this news page